Daihan Pharmaceutical Coltd Stock Z Score
023910 Stock | KRW 28,500 50.00 0.18% |
Daihan |
Daihan Pharmaceutical CoLtd Company Z Score Analysis
Daihan Pharmaceutical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Daihan Pharmaceutical Z Score | 7.8 |
Most of Daihan Pharmaceutical's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Daihan Pharmaceutical CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
In accordance with the company's disclosures, Daihan Pharmaceutical CoLtd has a Z Score of 7.8. This is 15.56% higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The z score for all Republic of Korea stocks is 10.55% higher than that of the company.
Daihan Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Daihan Pharmaceutical's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Daihan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Daihan Pharmaceutical by comparing valuation metrics of similar companies.Daihan Pharmaceutical is rated third in z score category among related companies.
Daihan Fundamentals
Return On Equity | 12.49 | |||
Return On Asset | 0.0677 | |||
Profit Margin | 0.10 % | |||
Operating Margin | 0.17 % | |||
Current Valuation | 148.23 B | |||
Shares Outstanding | 6 M | |||
Shares Owned By Insiders | 34.84 % | |||
Shares Owned By Institutions | 13.66 % | |||
Price To Earning | 11.74 X | |||
Price To Sales | 0.93 X | |||
Revenue | 171.46 B | |||
Gross Profit | 56.19 B | |||
EBITDA | 39.72 B | |||
Net Income | 22.67 B | |||
Cash And Equivalents | 83.73 B | |||
Total Debt | 14 B | |||
Debt To Equity | 0.15 % | |||
Current Ratio | 3.12 X | |||
Cash Flow From Operations | 40.62 B | |||
Target Price | 58000.0 | |||
Beta | 0.53 | |||
Market Capitalization | 182.1 B | |||
Total Asset | 272.54 B | |||
Retained Earnings | 67.17 B | |||
Working Capital | 33.04 B | |||
Current Asset | 75.05 B | |||
Current Liabilities | 42.01 B | |||
Z Score | 7.8 | |||
Annual Yield | 0.01 % | |||
Net Asset | 272.54 B |
About Daihan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Daihan Pharmaceutical CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Daihan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Daihan Pharmaceutical CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Daihan Pharmaceutical CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |